Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists
|
March 1, 2024
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials
Markus Dold, Hans-Jürgen Möller, Hans-Peter Volz, et al.
Journal of Psychiatric Research
|
March 12, 2017
Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study
Markus Dold, Lucie Bartova, Daniel Souery, et al.
Journal of Affective Disorders
|
November 7, 2017
Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study
Markus Dold, Lucie Bartova, Daniel Souery, et al.
Psychotherapy and Psychosomatics
|
October 2, 2019
The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials
Edda Pjrek, Michaela-Elena Friedrich, Luca Cambioli, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
February 17, 2020
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
Maximilian Huhn, Claudia Leucht, Philipp Rothe, et al.
Acta Psychiatrica Scandinavica
|
November 3, 2020
Combining machine learning algorithms for prediction of antidepressant treatment response
Alexander Kautzky, Hans-Juergen Möller, Markus Dold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 6, 2017
The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study
Markus Dold, Lucie Bartova, Alexander Kautzky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
November 18, 2018
Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study
Markus Dold, Lucie Bartova, Alexander Kautzky, et al.
The Journal of Clinical Psychiatry
|
January 25, 2019
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression
Markus Dold, Lucie Bartova, Alexander Kautzky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 30, 2018
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
European Psychiatry : the Journal of the Association of European Psychiatrists
|
March 1, 2024
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials
Markus Dold, Hans-Jürgen Möller, Hans-Peter Volz, et al.
Journal of Psychiatric Research
|
March 12, 2017
Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study
Markus Dold, Lucie Bartova, Daniel Souery, et al.
Journal of Affective Disorders
|
November 7, 2017
Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study
Markus Dold, Lucie Bartova, Daniel Souery, et al.
Psychotherapy and Psychosomatics
|
October 2, 2019
The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials
Edda Pjrek, Michaela-Elena Friedrich, Luca Cambioli, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
February 17, 2020
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
Maximilian Huhn, Claudia Leucht, Philipp Rothe, et al.
Acta Psychiatrica Scandinavica
|
November 3, 2020
Combining machine learning algorithms for prediction of antidepressant treatment response
Alexander Kautzky, Hans-Juergen Möller, Markus Dold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 6, 2017
The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study
Markus Dold, Lucie Bartova, Alexander Kautzky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
November 18, 2018
Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study
Markus Dold, Lucie Bartova, Alexander Kautzky, et al.
The Journal of Clinical Psychiatry
|
January 25, 2019
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression
Markus Dold, Lucie Bartova, Alexander Kautzky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 30, 2018
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Page
of 7